Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.45
-0.17 (-3.02%)
At close: Oct 2, 2026, 4:00 PM EDT
5.44
-0.01 (-0.18%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Alvotech Employees
Alvotech had 1,279 employees as of December 31, 2025. The number of employees increased by 267 or 26.38% compared to the previous year.
Employees
1,279
Change (1Y)
267
Growth (1Y)
26.38%
Revenue / Employee
$386,715
Profits / Employee
-$140,414
Market Cap
1.95B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,279 | 267 | 26.38% |
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | 88 | 12.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| HUTCHMED (China) | 1,790 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
ALVO News
- 16 days ago - Alvotech upgraded to Overweight from Underweight at Barclays - TheFly
- 17 days ago - Alvotech Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations - GlobeNewsWire
- 5 weeks ago - Alvotech to present at upcoming investor conferences in September - GlobeNewsWire
- 5 weeks ago - Alvotech initiated with a Buy at BofA - TheFly
- 6 weeks ago - Alvotech enters licensing, commercialization agreement with Lotus Pharmaceutical - TheFly
- 6 weeks ago - Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets - GlobeNewsWire
- 6 weeks ago - Alvotech Earnings Call Transcript: Q2 2026 - Transcripts